Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Short Term Loans and Advances

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Short Term Loans and Advances History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Short Term Loans and Advances ₹957 Cr₹1,011 Cr₹1,093 Cr₹657 Cr₹804 Cr

What is the latest Short Term Loans and Advances ratio of MANKIND PHARMA ?

The latest Short Term Loans and Advances ratio of MANKIND PHARMA is ₹957 Cr based on Mar2026 Consolidated results.
Year Short Term Loans and Advances
Mar2026₹957 Cr
Mar2025₹1,011 Cr
Mar2024₹1,093 Cr
Mar2023₹657 Cr
Mar2022₹804 Cr

How is Short Term Loans and Advances of MANKIND PHARMA Trending?

Years Short Term Loans and Advances % Change
Mar2026 ₹957 Cr
-5.35
Mar2025 ₹1,011 Cr
-7.56
Mar2024 ₹1,093 Cr
66.51
Mar2023 ₹657 Cr
-18.35
Mar2022 ₹804 Cr -

Compare Short Term Loans and Advances of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹100,352.8 Cr 6.2% 1.9% -10.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,196.0 Cr 1.8% -1.7% 14.6% Stock Analytics
DIVIS LABORATORIES ₹250,390.0 Cr 2.6% 9.8% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,967.0 Cr 2.4% -0.5% 36% Stock Analytics
CIPLA ₹111,888.0 Cr 1.8% -3.7% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹100,329.0 Cr 4.5% 1.8% -10% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

6.2%

1.9%

-10.3%

SENSEX

0.1%

-2.7%

-8.6%


You may also like the below Video Courses